经中长导管使用血管活性药物的安全性及有效性研究  

Safety and efficacy of vasoactive administered through medium catheters

作　　者：胡杨 文丹 HU Yang;WEN Dan(Department of Critical Care Medicine,Mianyang Central Hospital,School of Medicine,University of Electronic Science and Technology of China,Mianyang,Sichuan,621000,China)

机构地区：[1]电子科技大学医学院附属绵阳医院/绵阳市中心医院重症医学科,四川绵阳621000

出　　处：《当代医学》2024年第10期163-166,共4页Contemporary Medicine

摘　　要：目的确定通过中长导管(MC)长期给予血管活性药的安全性和有效性。方法回顾性分析2021年4月至2022年4月四川省绵阳市中心医院重症医学科使用MC输注血管活性药物的149例患者的临床资料,统计患者并发症发生情况,采用单因素及多因素Logistic回归分析MC导管相关并发症的危险因素。结果149例患者中发生导管相关并发症5例,发生率为3.4%。无并发症与有并发症患者留置时间、血管活性药物种类及药物输注时间比较差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,血管活性药物种类是MC导管相关并发症的危险性因素(P<0.05)。结论使用MC进行血管活性药物输注时应控制导管留置时间、减少药物种类及输注时间以降低导管相关并发症的发生率。Objective To determine the safety and efficacy of long-term vasoactive drug via midline venous catheters(MC).Methods The clinical data of 149 patients who received vasoactive drugs by MC from Mianyang Central Hospital from April 2021 to April 2022 were retrospectively analyzed.The risk factors of MC related complications were analyzed by univariate and multivariate Logistic regression.Results Among 149 patients,catheter-related complications occurred in 5 cases(3.4%).There were significant differences in MC indentation time,vasoactive drug types and drug infusion time between patients without complications and those with complications(P<0.05).Multivariate Logistic regression analysis showed that,the type of vasoactive drug used was the risk factor for MC related complications(P<0.05).Conclusion When MC are used for vasoactive drug infusion,catheter indentation time,drug types and infusion time should be controlled to reduce the incidence of catheter related complications.

关 键 词：中长导管 血管活性药 静脉治疗 

分 类 号：R47[医药卫生—护理学]